 Mar 18 - 19, 2010
 New York
This is the only conference that allows you to see the complete pricing and reimbursement picture. This annual program gives full coverage of all the new developments from the leading industry experts, including in-house pricing experts and a regular stellar faculty of government enforcers.
|
 Mar 24 - 25, 2010
 New York
FDA Boot Camp – New York has been designed to give products or patent litigators, as well as patent prosecutors and life sciences investment and securities experts, a strong working knowledge of core FDA regulatory competencies, including the nuances of the one of the most comprehensive revisions of FDA law in decades, the FDA Amendments Act of 2007 (FDAAA).
|
 Mar 24 - 25, 2010
 New York
The 10th National, Fraud & Abuse in the Sale and Marketing of Drugs will provide you with the most-up-to-date insights into how to reshape your compliance programs to reflect changes in enforcement priorities while also developing corporate policies that will protect against future fraud claims. |
 Apr 14 - 15, 2010
 Philadelphia
This program will identify the best practices for pharmaceutical companies when developing advertising and marketing campaigns |
 Apr 19 - 20, 2010
 New York
Managing product Risks and Complying with FDAAA Safety Regulations |
 Apr 27 - 28, 2010
 New York
ACI’s conference on Paragraph IV Disputes is the premier original event where both brand name and generic companies can come to hear insights from a top-notch faculty on every facet of Paragraph IV litigation, from pre-litigation concerns to the commencem |
 Apr 27 - 28, 2010
 Chicago
This conference will feature an industry-leading faculty of in-house and experienced attorneys who will offer specific insights into what conduct the government looks for, and hohow to best situate your company to be able to withstand scrutiny. |
 Apr 29 - 30, 2010
 Washington
In its third iteration, ACI’s National Forum on OFAC Compliance and Enforcement will assemble an exceptional faculty of leading industry executives, attorneys and government officials who will analyze the latest information on how OFAC measures the nature and extent of cooperation, what OFAC guidelines reveal about the essential components of an effective sanctions compliance program, and much more! |
 May 17 - 18, 2010
 New York
ACI’s FCPA and International Anti-Corruption for the Pharmaceutical and Medical Device Industries will provide you with the comprehensive legal and compliance information essential to formulate and hone proactive strategies for successfully protecting your company and clients before, during, and after a government investigation. |
 May 17 - 18, 2010
 New York
ACI has assembled a faculty of the government authorities on “Big Four” pricing and pharmacy benefits programs along with expert pricing practitioners. This distinguished faculty will make sense of complicated terminology and pricing calculations and teach you how to navigate the complexities of working with the “Big Four” agencies. |
 May 24 - 25, 2010
 Philadelphia
The agenda is currently in production. Interested speakers should contact Ms. Dana Rossi at: d.rossi@americanconference.com
|
 May 24 - 25, 2010
 San Diego
A Primer on IP Basics and Regulatory Fundamentals Relative to Small Molecules and Biologics for Brand Names, Generics and Biopharmas |
 May 25 - 26, 2010
 San Francisco
ACI has created Rx Drug Pricing Boot Camp. Now in its fourth year, this program provides drug manufacturers, PBMs, plans, and pharmacies with the critical information they need to effectively and efficiently manage government pricing. |
 Jun 15 - 16, 2010
 Chicago
Prepare now for contemplated changes affecting pricing, reimbursement and payment in the Medical Device Industry. Understand how proposed reforms will factor into the existing regulatory schematic. |
 Jun 22 - 23, 2010
 Philadelphia
Medical professionals from top hospital systems around the country, as well as the top legal practitioners and claims experts, will help you achieve your company or client’s objectives while minimizing the risks of liability. |